Idiopathic interstitial pneumonia natural history, complications and prognosis: Difference between revisions
Ahmed Zaghw (talk | contribs) |
Ahmed Zaghw (talk | contribs) |
||
Line 7: | Line 7: | ||
==Natural history and Complications== | ==Natural history and Complications== | ||
==Major Idiopathic Interstitial Pneumonias== | s==Major Idiopathic Interstitial Pneumonias== | ||
* Chronic fibrosing IIPs: | * [[Chronic fibrosing IIPs]]: | ||
:* [[Idiopathic pulmonary fibrosis]], the most common | :* [[Idiopathic pulmonary fibrosis]], the most common | ||
:* [[Idiopathic nonspecific interstitial pneumonia]] | :* [[Idiopathic nonspecific interstitial pneumonia]] | ||
*Acute/Subacute IIPs: | * [[Acute/Subacute IIPs]]: | ||
:* [[Cryptogenic organizing pneumonia]] | :* [[Cryptogenic organizing pneumonia]] | ||
:* [[Acute interstitial pneumonia]] | :* [[Acute interstitial pneumonia]] (Hamman-Rich Syndrome) | ||
*Smoking-related IIPs: | * [[Smoking-related IIPs]]: | ||
:* [[Respiratory bronchiolitis-interstitial lung disease]] | :* [[Respiratory bronchiolitis-interstitial lung disease]] | ||
Revision as of 16:48, 18 November 2013
Idiopathic Interstitial Pneumonia Microchapters |
Differentiating Idiopathic interstitial pneumonia from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Idiopathic interstitial pneumonia natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Idiopathic interstitial pneumonia natural history, complications and prognosis |
FDA onIdiopathic interstitial pneumonia natural history, complications and prognosis |
CDC on Idiopathic interstitial pneumonia natural history, complications and prognosis |
Idiopathic interstitial pneumonia natural history, complications and prognosisin the news |
on Idiopathic interstitial pneumonia natural history, complications and prognosis |
Directions to Hospitals Treating Idiopathic interstitial pneumonia |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]
Overview
Natural history and Complications
s==Major Idiopathic Interstitial Pneumonias==
- Cryptogenic organizing pneumonia
- Acute interstitial pneumonia (Hamman-Rich Syndrome)
Rare Idiopathic Interstitial Pneumonias
- Idiopathic lymphoid interstitial pneumonia
- Idiopathic pleuroparenchymal fibroelastosis
Biomarkers
The functional lung capacity, pulmonary functions and mortality have been linked to some biomarkers. For example some studies showed that rapidly deteriorating lung function and higher mortality have been associated with high serum level of epithelial or macrophage-related proteins such as SP-A, SP-D, KL-6 (Krebs von den Lungen-6), CCL18 (chemokine ligand-18), and MMP-7 (matrix metalloproteinase-7) [1] [2] [3]
References
- ↑ Satoh, H.; Kurishima, K.; Ishikawa, H.; Ohtsuka, M. (2006). "Increased levels of KL-6 and subsequent mortality in patients with interstitial lung diseases". J Intern Med. 260 (5): 429–34. doi:10.1111/j.1365-2796.2006.01704.x. PMID 17040248. Unknown parameter
|month=
ignored (help) - ↑ Prasse, A.; Probst, C.; Bargagli, E.; Zissel, G.; Toews, GB.; Flaherty, KR.; Olschewski, M.; Rottoli, P.; Müller-Quernheim, J. (2009). "Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis". Am J Respir Crit Care Med. 179 (8): 717–23. doi:10.1164/rccm.200808-1201OC. PMID 19179488. Unknown parameter
|month=
ignored (help) - ↑ Ishii, H.; Mukae, H.; Kadota, J.; Kaida, H.; Nagata, T.; Abe, K.; Matsukura, S.; Kohno, S. (2003). "High serum concentrations of surfactant protein A in usual interstitial pneumonia compared with non-specific interstitial pneumonia". Thorax. 58 (1): 52–7. PMID 12511721. Unknown parameter
|month=
ignored (help)